Yantai LNC Biotechnology Singapore

LNC Biotechnology is a clinical-stage regenerative medicine company specializing in the development of mesenchymal stem cell (MSC) therapies. As a subsidiary of the Luye Life Sciences Group, the company maintains a dual presence in Yantai, China, and Singapore to drive global R&D and clinical translation. Their primary focus areas include orthopedics, particularly osteoarthritis, and advanced wound care, utilizing proprietary isolation and expansion technologies. The company operates integrated GMP-compliant manufacturing facilities to ensure the quality and scalability of its cell-based products. LNC Biotechnology aims to address significant unmet medical needs by integrating cell therapy with advanced delivery systems for chronic and age-related diseases.